Intraop Medical, Inc. announced today that a European Consortium
for Research in IORT Studies (“ECRIS”) has been formed. The founding members of ECRIS are
Hospital Gregorio Maranon, Madrid, Spain;
Institut Gustave Roussey, Paris France;
Centre Oscar Lambret, Lille, France;
Catharina Ziekenhuis, Eindhoven, the Netherlands;
University of Heidelberg, Heidelberg, Germany;
Ospedale Maggiore della Carita of the University of Piemonte Orientale in Novara Italy;
The European Institute of Oncology, Milan, Italy, University of Torino, Torino, Italy,
and Catholic University, Rome, Italy.
Also invited to participate in ECRIS is the University of North Carolina at Chapel Hill, North Carolina who will contribute its expertise
in IORT radiobiology and its IORT breast protocol, and the University of California at San Francisco,
San Francisco, California who has been selected for their recognized expertise in pediatric IORT.
ECRIS will have their first organizational meeting in Novara, Italy in Spring 2005 to establish the guidelines
for their operation. Intraop Medical will provide logistical support to the participants and to ECRIS. Among
the tumor sites that are expected to be studied by ECRIS will be pancreatic cancer, rectal cancer, sarcomas,
lung cancer, breast cancer, prostate cancer, and pediatric cancer.
ECRIS is unique in that it will facilitate the initiation of prospective studies in IORT. With more than
30,000 cancer patients under treatment each year at the member centers, ECRIS is expected to be able to
rapidly accrue IORT patients in their study protocols. Other interested European centers with strong
IORT interest and capability will be invited to participate in ECRIS.
